The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice

BACKGROUND: Recent studies in the NOD (non-obese diabetic) mouse model of type 1 diabetes (T1D) support the notion that tyrosine kinase inhibitors have the potential for modulating disease development. However, the therapeutic effects of AG490 on the development of T1D are unknown. MATERIALS AND MET...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Davoodi-Semiromi, Abdoreza, Wasserfall, Clive H., Xia, Chang Qing, Cooper-DeHoff, Rhonda M., Wabitsch, Martin, Clare-Salzler, Michael, Atkinson, Mark
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2012
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351395/
https://ncbi.nlm.nih.gov/pubmed/22615750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0036079
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg